Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPPETRONI, Ricardo CostaBISELLI, Paolo Jose CesareLIMA, Thais Martins deVELASCO, Irineu TadeuSORIANO, Francisco Garcia2016-02-112016-02-112015SHOCK, v.44, n.6, p.609-615, 20151073-2322https://observatorio.fm.usp.br/handle/OPI/12613Acute lung injury (ALI) is a common complication associated with septic shock that directly influences the prognosis of sepsis patients. Currently, one of the main supportive treatment modalities for septic shock is fluid resuscitation. The use of hypertonic saline (HS: 7.5% NaCl) for fluid resuscitation has been described as a promising therapy in experimental models of sepsis-induced ALI, but it has failed to produce similar results in clinical practice. Thus, we compared experimental timing versus clinical timing effectiveness (i.e., early vs. late fluid resuscitation) after the inflammatory scenario was established in a rat model of bacterial lipopolysaccharide-induced ALI. We found that late fluid resuscitation with hypertonic saline (NaCl 7.5%) did not reduce the mortality rates of animals compared with the mortality late associated with early treatment. Late fluid resuscitation with both hypertonic and normal saline increased pulmonary inflammation, decreased pulmonary function, and induced pulmonary injury by elevating metalloproteinase-2 and metalloproteinase-9 activity and collagen deposition in the animals, unlike early treatment. The animals with lipopolysaccharide-induced ALI that received late resuscitation with any kind of fluids demonstrated aggravated pulmonary injury and respiratory function. Moreover, we showed that the therapeutic window for a beneficial effect of fluid resuscitation with hypertonic saline is very narrow.engrestrictedAccessAcute lung injurycytokinesfluid resuscitationinflammationsepsisnf-kappa-binflammatory responseendotoxemic ratsseptic shocksepsisexpressionmodelgenepcrarticleCopyright LIPPINCOTT WILLIAMS & WILKINS10.1097/SHK.0000000000000461Critical Care MedicineHematologySurgeryPeripheral Vascular Disease1540-0514